$610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma$

610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma

Bibliographic Details
Main Authors:	Shailender Bhatia, Ramesh Rengan, Sylvia M Lee, Scott S Tykodi, Jing Zeng, Mary Redman, Peter H Goff, Kelsey K Baker
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference
by: Fabiana Gregucci, et al.
Published: (2023-12-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
by: Rosi Bissinger, et al.
Published: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
by: Lenka Besse, et al.
Published: (2023-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
by: Anna Gidari, et al.
Published: (2022-12-01)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
by: Mahbuba R. Subeha, et al.
Published: (2020-11-01)

The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer
by: Marcin Miszczyk, et al.
Published: (2022-03-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
by: Holyoake, D, et al.
Published: (2016)

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
by: Choudhury, A, et al.
Published: (2011)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
by: Al-Assar, O, et al.
Published: (2016)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
by: V. B. Denisenko,, et al.
Published: (2018-12-01)

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
by: Ohashi, H, et al.
Published: (2021)

Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly
by: Maggie Li, et al.
Published: (2024-03-01)

Workshop manual for Datsun 510 and 610 series/
by: 245761 Newton, C. R.
Published: (1972)

HYPOFRACTIONATED RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY WITH WEEKLY CISPLATIN IN LOCALLY ADVANCED RELATIVELY RADIORESISTENT SUBSITES OF HEAD AND NECK CANCERS
by: K. Baidya, et al.
Published: (2023-03-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
by: Hill, E, et al.
Published: (2016)

A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
by: Choudhury, A, et al.
Published: (2010)

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide
by: Fabiana Gregucci, et al.
Published: (2021-11-01)

AGW 610 - FINANCE ACCOUNTING FOR MANAGEMENT SEPT 99.
by: PPP, Pusat Pengajian Pengurusan
Published: (1999)

AGU 610 - INTERNATIONAL BUSINESS MANAGEMENT APRIL 08
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)

AGW610- Finance & Accounting For Management (September 1997)
by: PPP, Pusat Pengajian Pengurusan
Published: (1997)

AGW 610 - FINANCE ACCOUNTING FOR MANAGEMENT SEPT 1999.
by: PPP, Pusat Pengajian Pengurusan
Published: (1999)

AGW 610 - FINANCE & ACCOUNTING FOR MANAGEMENT SEPT 1997.
by: PPP, Pusat Pengajian Pengurusan
Published: (1997)

AGU 610 — International Business Management - February 2000
by: PPP, Pusat Pengajian Pengurusan
Published: (2000)

Mettools V 610 October 2003, Essen, Germany
by: Wilhelm Kuttler
Published: (2004-10-01)

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
by: FangJie Liu, et al.
Published: (2022-11-01)

Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma
by: Dominika Fassmannová, et al.
Published: (2020-04-01)

The Role of Hypofractionation in Proton Therapy
by: Alexandre Santos, et al.
Published: (2022-05-01)

AGW610 - Finance And Accounting For Management - August - September 1998
by: PPP, Pusat Pengajian Pengurusan
Published: (1998)

AGW 610 - FINANCE & ACCOUNTING FOR MANAGEMENT SEPT 1997.pdf
by: PPP, Pusat Pengajian Pengurusan
Published: (1997)

AGW 610 - FINANCE ACCOUNTING FOR MANAGEMENT SEPT 1999.pdf
by: PPP, Pusat Pengajian Pengurusan
Published: (1999)

Non-Isothermal Crystallization Kinetics of Montmorillonite/Polyamide 610 Nanocomposites
by: Yang Fu, et al.
Published: (2023-06-01)

İSLÂM VE DOĞU HIRİSTİYANLARI: MEKKE MİLÂDÎ 610-622
by: Zekiye Sönmez
Published: (2017-06-01)

ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation
by: Wang, Andrew Z, et al.
Published: (2021)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
by: Brunner, T, et al.
Published: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
by: Brunner, T, et al.
Published: (2008)

A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19
by: Taiga Miyazaki, et al.
Published: (2023-06-01)

Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2
by: Zhijian Xu, et al.
Published: (2023-04-01)

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment
by: Henry D. McCann, et al.
Published: (2018-10-01)

A multicenter randomized controlled trial to evaluate the efficacy and safety of nelfinavir in patients with mild COVID-19
by: Miyazaki, T, et al.
Published: (2023)

Editorial: ImmunoPhysics and ImmunoEngineering
by: de la Serna, JB, et al.
Published: (2020)